Addex wins $1m Michael J Fox Foundation grant for Parkinson’s disease research
Dipraglurant is an oral, small molecule allosteric modulator with a potential to be used as combination therapy with levodopa or dopamine agonists or as a standalone treatment for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.